MRZM OTC
Marizyme, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +29900.0%
3Y: -99.7%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$646K
+176.6% ▲
5Y CAGR: +100.0%
Gross Profit
$239K
+33.3% ▲
5Y CAGR: +362.4%
Operating Income
-$34M
-162.7% ▼
Net Income
-$70M
-82.2% ▼
EPS (Diluted)
$-1.53
-62.8% ▼
EBITDA
-$55M
-60.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $197K | $210K | $233K | $646K |
| YoY Growth | -100.0% | +0.0% | +6.7% | +11.0% | +176.6% |
| Cost of Revenue | $0 | $58K | $80K | $54K | $407K |
| Gross Profit | $0 | $139K | $130K | $179K | $239K |
| Gross Margin | — | 70.4% | 61.8% | 76.7% | 37.0% |
| R&D Expenses | $0 | $688K | $2M | $4M | $2M |
| SG&A Expenses | $111K | $5M | $7M | $8M | $17M |
| Operating Expenses | $1M | $6M | $9M | $13M | $34M |
| Operating Income | -$1M | -$6M | -$9M | -$13M | -$34M |
| Operating Margin | — | -2941.9% | -4195.1% | -5556.6% | -5278.1% |
| Interest Expense | $0 | $45K | $126K | $3M | $30M |
| Income Before Tax | -$1M | -$6M | -$11M | -$38M | -$65M |
| Tax Expense | $0 | $0 | $0 | $0 | $4M |
| Net Income | -$1M | -$6M | -$11M | -$38M | -$70M |
| Net Margin | — | -2965.0% | -5230.2% | -16346.2% | -10767.8% |
| EPS (Diluted) | $-0.05 | $-0.22 | $-0.31 | $-0.94 | $-1.53 |
| EBITDA | $0 | -$5M | -$11M | -$35M | -$55M |
| Shares Outstanding | 20M | 26M | 36M | 41M | 45M |